Saint John Cancer Institute

Santa Monica, California 90404

1 studies enrolling now · 2 studies all time

What they study most

Glioblastoma Multiforme, Residual, Progressive or Recurrent Grade II or III Meningioma

Studies at this site

• NEO100 and High-Grade Meningioma — Recruiting now
• Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma — Running, not enrolling